Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
The Right Time & The Right Place
By Christine Filippis / January 20, 2022
Cartherics welcomes a new Senior Research Fellow who says she has finally found The Right Job By Leigh Dayton, 20...
Read More
‘Off-the-Shelf’ Immunotherapy Gets Special Treatment in Special Issue of The Journal Cells
By Christine Filippis / January 17, 2022
Thanks go to Special Editor, Cartherics CEO Alan Trounson By Leigh Dayton, 17 January 2022 Cellular immunotherapy is revolutionizing cancer...
Read More
A Star is Born! Cartherics student takes out top award …..
By Christine Filippis / January 4, 2022
By Leigh Dayton, 4 January 2022 When Cartherics Biomedical Honours student Elizabeth (Liz) Bakaniozos opened an e-mail this month from...
Read More
